Report Detail
Global Chemotherapy for Neuroblastoma Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4538725 |
- 10 July, 2023 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Chemotherapy for Neuroblastoma market size was valued at USD 126.6 million in 2022 and is forecast to a readjusted size of USD 171.1 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Chemotherapy (chemo) is the use of anti-cancer drugs, which are usually given into a vein. The drugs enter the bloodstream and travel throughout the body to reach and destroy cancer cells. This makes chemo useful for treating neuroblastoma, especially if it can't all be removed with surgery. The most common combination of drugs includes cisplatin (or carboplatin), cyclophosphamide, doxorubicin, vincristine, and etoposide, but others may be used.
This report is a detailed and comprehensive analysis for global Chemotherapy for Neuroblastoma market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Chemotherapy for Neuroblastoma market size and forecasts, in consumption value ($ Million), 2018-2029
Global Chemotherapy for Neuroblastoma market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Chemotherapy for Neuroblastoma market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Chemotherapy for Neuroblastoma market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chemotherapy for Neuroblastoma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chemotherapy for Neuroblastoma market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter Healthcare, Ingenus Pharmaceuticals, ANI Pharmaceuticals, Teva Pharmaceuticals and Qilu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Chemotherapy for Neuroblastoma market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cyclophosphamide
Cisplatin or Carboplatin
Vincristine
Doxorubicin (Adriamycin)
Etoposide
Other
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Baxter Healthcare
Ingenus Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceuticals
Qilu Pharmaceutical
Pfizer
Hikma Pharmaceuticals
Fresenius Kabi
Accord Healthcare
Viatris
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chemotherapy for Neuroblastoma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chemotherapy for Neuroblastoma, with revenue, gross margin and global market share of Chemotherapy for Neuroblastoma from 2018 to 2023.
Chapter 3, the Chemotherapy for Neuroblastoma competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Chemotherapy for Neuroblastoma market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Chemotherapy for Neuroblastoma.
Chapter 13, to describe Chemotherapy for Neuroblastoma research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Chemotherapy for Neuroblastoma
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Chemotherapy for Neuroblastoma by Type
- 1.3.1 Overview: Global Chemotherapy for Neuroblastoma Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Chemotherapy for Neuroblastoma Consumption Value Market Share by Type in 2022
- 1.3.3 Cyclophosphamide
- 1.3.4 Cisplatin or Carboplatin
- 1.3.5 Vincristine
- 1.3.6 Doxorubicin (Adriamycin)
- 1.3.7 Etoposide
- 1.3.8 Other
- 1.4 Global Chemotherapy for Neuroblastoma Market by Application
- 1.4.1 Overview: Global Chemotherapy for Neuroblastoma Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Chemotherapy for Neuroblastoma Market Size & Forecast
- 1.6 Global Chemotherapy for Neuroblastoma Market Size and Forecast by Region
- 1.6.1 Global Chemotherapy for Neuroblastoma Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Chemotherapy for Neuroblastoma Market Size by Region, (2018-2029)
- 1.6.3 North America Chemotherapy for Neuroblastoma Market Size and Prospect (2018-2029)
- 1.6.4 Europe Chemotherapy for Neuroblastoma Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Chemotherapy for Neuroblastoma Market Size and Prospect (2018-2029)
- 1.6.6 South America Chemotherapy for Neuroblastoma Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Chemotherapy for Neuroblastoma Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Baxter Healthcare
- 2.1.1 Baxter Healthcare Details
- 2.1.2 Baxter Healthcare Major Business
- 2.1.3 Baxter Healthcare Chemotherapy for Neuroblastoma Product and Solutions
- 2.1.4 Baxter Healthcare Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Baxter Healthcare Recent Developments and Future Plans
- 2.2 Ingenus Pharmaceuticals
- 2.2.1 Ingenus Pharmaceuticals Details
- 2.2.2 Ingenus Pharmaceuticals Major Business
- 2.2.3 Ingenus Pharmaceuticals Chemotherapy for Neuroblastoma Product and Solutions
- 2.2.4 Ingenus Pharmaceuticals Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Ingenus Pharmaceuticals Recent Developments and Future Plans
- 2.3 ANI Pharmaceuticals
- 2.3.1 ANI Pharmaceuticals Details
- 2.3.2 ANI Pharmaceuticals Major Business
- 2.3.3 ANI Pharmaceuticals Chemotherapy for Neuroblastoma Product and Solutions
- 2.3.4 ANI Pharmaceuticals Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 ANI Pharmaceuticals Recent Developments and Future Plans
- 2.4 Teva Pharmaceuticals
- 2.4.1 Teva Pharmaceuticals Details
- 2.4.2 Teva Pharmaceuticals Major Business
- 2.4.3 Teva Pharmaceuticals Chemotherapy for Neuroblastoma Product and Solutions
- 2.4.4 Teva Pharmaceuticals Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Teva Pharmaceuticals Recent Developments and Future Plans
- 2.5 Qilu Pharmaceutical
- 2.5.1 Qilu Pharmaceutical Details
- 2.5.2 Qilu Pharmaceutical Major Business
- 2.5.3 Qilu Pharmaceutical Chemotherapy for Neuroblastoma Product and Solutions
- 2.5.4 Qilu Pharmaceutical Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Qilu Pharmaceutical Recent Developments and Future Plans
- 2.6 Pfizer
- 2.6.1 Pfizer Details
- 2.6.2 Pfizer Major Business
- 2.6.3 Pfizer Chemotherapy for Neuroblastoma Product and Solutions
- 2.6.4 Pfizer Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Pfizer Recent Developments and Future Plans
- 2.7 Hikma Pharmaceuticals
- 2.7.1 Hikma Pharmaceuticals Details
- 2.7.2 Hikma Pharmaceuticals Major Business
- 2.7.3 Hikma Pharmaceuticals Chemotherapy for Neuroblastoma Product and Solutions
- 2.7.4 Hikma Pharmaceuticals Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Hikma Pharmaceuticals Recent Developments and Future Plans
- 2.8 Fresenius Kabi
- 2.8.1 Fresenius Kabi Details
- 2.8.2 Fresenius Kabi Major Business
- 2.8.3 Fresenius Kabi Chemotherapy for Neuroblastoma Product and Solutions
- 2.8.4 Fresenius Kabi Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Fresenius Kabi Recent Developments and Future Plans
- 2.9 Accord Healthcare
- 2.9.1 Accord Healthcare Details
- 2.9.2 Accord Healthcare Major Business
- 2.9.3 Accord Healthcare Chemotherapy for Neuroblastoma Product and Solutions
- 2.9.4 Accord Healthcare Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Accord Healthcare Recent Developments and Future Plans
- 2.10 Viatris
- 2.10.1 Viatris Details
- 2.10.2 Viatris Major Business
- 2.10.3 Viatris Chemotherapy for Neuroblastoma Product and Solutions
- 2.10.4 Viatris Chemotherapy for Neuroblastoma Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Viatris Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Chemotherapy for Neuroblastoma Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Chemotherapy for Neuroblastoma by Company Revenue
- 3.2.2 Top 3 Chemotherapy for Neuroblastoma Players Market Share in 2022
- 3.2.3 Top 6 Chemotherapy for Neuroblastoma Players Market Share in 2022
- 3.3 Chemotherapy for Neuroblastoma Market: Overall Company Footprint Analysis
- 3.3.1 Chemotherapy for Neuroblastoma Market: Region Footprint
- 3.3.2 Chemotherapy for Neuroblastoma Market: Company Product Type Footprint
- 3.3.3 Chemotherapy for Neuroblastoma Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Chemotherapy for Neuroblastoma Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Chemotherapy for Neuroblastoma Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Chemotherapy for Neuroblastoma Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Chemotherapy for Neuroblastoma Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Chemotherapy for Neuroblastoma Consumption Value by Type (2018-2029)
- 6.2 North America Chemotherapy for Neuroblastoma Consumption Value by Application (2018-2029)
- 6.3 North America Chemotherapy for Neuroblastoma Market Size by Country
- 6.3.1 North America Chemotherapy for Neuroblastoma Consumption Value by Country (2018-2029)
- 6.3.2 United States Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 6.3.3 Canada Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Chemotherapy for Neuroblastoma Consumption Value by Type (2018-2029)
- 7.2 Europe Chemotherapy for Neuroblastoma Consumption Value by Application (2018-2029)
- 7.3 Europe Chemotherapy for Neuroblastoma Market Size by Country
- 7.3.1 Europe Chemotherapy for Neuroblastoma Consumption Value by Country (2018-2029)
- 7.3.2 Germany Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 7.3.3 France Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 7.3.5 Russia Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 7.3.6 Italy Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Chemotherapy for Neuroblastoma Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Chemotherapy for Neuroblastoma Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Chemotherapy for Neuroblastoma Market Size by Region
- 8.3.1 Asia-Pacific Chemotherapy for Neuroblastoma Consumption Value by Region (2018-2029)
- 8.3.2 China Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 8.3.3 Japan Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 8.3.5 India Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 8.3.7 Australia Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Chemotherapy for Neuroblastoma Consumption Value by Type (2018-2029)
- 9.2 South America Chemotherapy for Neuroblastoma Consumption Value by Application (2018-2029)
- 9.3 South America Chemotherapy for Neuroblastoma Market Size by Country
- 9.3.1 South America Chemotherapy for Neuroblastoma Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Chemotherapy for Neuroblastoma Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Chemotherapy for Neuroblastoma Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Chemotherapy for Neuroblastoma Market Size by Country
- 10.3.1 Middle East & Africa Chemotherapy for Neuroblastoma Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
- 10.3.4 UAE Chemotherapy for Neuroblastoma Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Chemotherapy for Neuroblastoma Market Drivers
- 11.2 Chemotherapy for Neuroblastoma Market Restraints
- 11.3 Chemotherapy for Neuroblastoma Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Chemotherapy for Neuroblastoma Industry Chain
- 12.2 Chemotherapy for Neuroblastoma Upstream Analysis
- 12.3 Chemotherapy for Neuroblastoma Midstream Analysis
- 12.4 Chemotherapy for Neuroblastoma Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Chemotherapy for Neuroblastoma. Industry analysis & Market Report on Chemotherapy for Neuroblastoma is a syndicated market report, published as Global Chemotherapy for Neuroblastoma Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Chemotherapy for Neuroblastoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
